Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.

Morand du Puch CB, Vanderstraete M, Giraud S, Lautrette C, Christou N, Mathonnet M

Open source

DOI
10.7150/thno.55954
Published
2021
Container
Theranostics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7150/thno.55954,
  title = {Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.},
  author = {Morand du Puch CB and Vanderstraete M and Giraud S and Lautrette C and Christou N and Mathonnet M},
  year = {2021},
  journal = {Theranostics},
  doi = {10.7150/thno.55954},
  url = {https://doi.org/10.7150/thno.55954}
}

RIS

TY  - JOUR
TI  - Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.
AU  - Morand du Puch CB
AU  - Vanderstraete M
AU  - Giraud S
AU  - Lautrette C
AU  - Christou N
AU  - Mathonnet M
PY  - 2021
JO  - Theranostics
DO  - 10.7150/thno.55954
UR  - https://doi.org/10.7150/thno.55954
ER  - 

APA

CB, M. D. P., M, V., S, G., C, L., N, C., & M, M. (2021). Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.. Theranostics. https://doi.org/10.7150/thno.55954

Source records